Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

Emilio Bria, Giacomo Bertelli, Rosalinda Trovato, Stefano Ugel, Michele Milella, Vincenzo Bronte, Sara Pilotto

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

N/A
Original languageEnglish
Pages (from-to)e514-e516
Number of pages3
JournalClinical Lung Cancer
Volume20
DOIs
Publication statusPublished - 2019

Keywords

  • Immunotherapy
  • MDSC
  • NSCLC
  • Predictive biomarkers
  • Tumor-induced immunosuppression

Fingerprint

Dive into the research topics of 'Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report'. Together they form a unique fingerprint.

Cite this